Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

Recently, we have shown that metastasis-free survival is a strong surrogate for overall survival (OS) in men with intermediate- and high-risk localized prostate cancer and can accelerate the evaluation of new (neo)adjuvant therapies. Event-free survival (EFS), an earlier prostate-specific antigen (P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Xie, Wanling, Regan, Meredith M., Buyse, Marc, Halabi, Susan, Kantoff, Philip W., Sartor, Oliver, Soule, Howard, Berry, Donald, Clarke, Noel, Collette, Laurence, D’Amico, Anthony, Lourenco, Richard De Abreu, Dignam, James, Eisenberger, Mario, James, Nicholas, Fizazi, Karim, Gillessen, Silke, Loriot, Yohann, Mottet, Nicolas, Parulekar, Wendy, Sandler, Howard, Spratt, Daniel E., Sydes, Matthew R., Tombal, Bertrand, Williams, Scott, Sweeney, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265328/
https://ncbi.nlm.nih.gov/pubmed/32552276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.03114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados